Effect of growth hormone (GH) and/or testosterone replacement on the prostate in GH-deficient adult patients

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 1, 2003, Pages 88-94

  Colao, Annamaria ^a   Di Somma, Carolina ^a   Spiezia, Stefano ^b   Filippella, Mariagiovanna ^a   Pivonello, Rosario ^a   Lombardi, Gaetano ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Santa Maria del P degli I H of N   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE;

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITY; DRUG EFFECT; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MALE; ORGAN SIZE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

ADULT; AGED; ANDROGENS; DRUG THERAPY, COMBINATION; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; LONGITUDINAL STUDIES; MALE; METABOLISM, INBORN ERRORS; MIDDLE AGED; ORGAN SIZE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; TESTOSTERONE;

EID: 0037238612     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020812     Document Type: Article

References (34)

1. Cohen P 1998 Serum insulin-like growth factor-I levels and prostate cancer risk: interpreting the evidence. J Natl Cancer Inst 90:876-879
2. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M 1998 Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279:563-566
3. Wolk A, Mantzoros CS, Andersson SO, Bergstrom R, Signorello LB, Lagiou P, Adami HO, Trichopoulos D 1998 Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst 90:911-915
4. Grimberg A, Rajah R, Zhao H, Cohen P 1998 The prostatic IGF system: new levels of complexity. In: Takano K, Hizuka N, Takahashi SI, eds. Molecular mechanisms to regulate the activities of insulin-like growth factors. Amsterdam: Elsevier; 205-215
5. Cohen P, Peehl DM, Lamson G, Rosenfeld RG 1991 Insulin-like growth factors (IGFs), IGF receptors and IGF binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab 73:491-497
6. Colao A, Marzullo P, Ferone D, Spiezia S, Cerbone G, Marino V, Di Sarno A, Merola B, Lombardi G 1998 Prostate hyperplasia: an unknown feature of acromegaly. J Clin Endocrinol Metab 83:775-779
7. Colao A, Marzullo P, Spiezia S, Ferone D, Giaccio A, Cerbone G, Pivonello R, Di Somma C, Lombardi G 1999 Effect of growth hormone (GH) and insulin-like growth factor-1 on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH-deficiency and healthy subjects. J Clin Endocrinol Metab 84:1986-1991
8. Colao A, Marzullo P, Spiezia S, Giaccio A, Ferone D, Cerbone G, Di Sarno A, Lombardi G 2000 Effect of two years of growth hormone and insulin-like growth factor-I suppression on prostate diseases in acromegalic patients. J Clin Endocrinol Metab 85:3754-3761
9. Colao A, Spiezia S, Di Somma C, Marzullo P, Cerbone G, Pivonello R, Faggiano A, Lombardi G 2000 Effect of growth hormone (GH) and/or testosterone deficiency on the prostate: an ultrasonographic and endocrine study in GH deficient adult patients. Eur J Endocrinol 143:61-69
10. Carrol PV, Christ ER 1998 Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. J Clin Endocrinol Metab 83:382-395
11. Vance ML, Mauras N 1999 Growth hormone therapy in adults and children. N Engl J Med 341:1206-1216
12. Bengtsson BA, Johannsson G, Shalet SM, Simpson H, Sonken PH 2000 Treatment of growth hormone deficiency in adults. J Clin Endocrinol Metab 85:933-942
13. Colao A, Di Somma C, Pivonello R, Cuocolo A, Spinelli L, Bonaduce D, Salvatore M, Lombardi G 2002 The cardiovascular risk of adult growth hormone (GH) deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12 month prospective study. J Clin Endocrinol Metab 87:1088-1093
14. Toogood A, Beardwell CG, Shalet SM 1994 The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clin Endocrinol (Oxf) 41:511-516
15. Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Arvat E, Camanni F, Ghigo E 1998 Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab 83:1615-1618
16. Colao A, Cerbone G, Pivonello R, Aimaretti G, Loche S, Di Somma C, Faggiano A, Corneli G, Ghigo E, Lombardi G 1999 The growth hormone (GH) response to arginine plus GH releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency. J Clin Endocrinol Metab 84:1277-1282
17. Colao A, Di Somma C, Pivonello R, Loche S, Aimaretti G, Cerbone G, Faggiano A, Corneli G, Ghigo E, Lombardi G 1999 Bone loss is correlated to the severity of growth hormone (GH) deficiency in adult patients with hypopituitarism. J Clin Endocrinol Metab 84:1919-1924
18. Ciatto S, Bonardi R, Lombardi C, Cappelli G, Castagnoli A, D'Agata A, Zappa M, Gervasi G 2001 Predicting prostate biopsy outcome by findings at digital rectal examination, transrectal ultrasonography, PSA, PSA density and free-to-total PSA ratio in a population-based screening setting. Int J Biol Markers 16:179-182
19. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR 2001 Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 86:724-731
20. Barrett-Connor E, Von Muhlen DG, Kritz-Silverstein D 1999 Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J Clin Endocrinol Metab 84:573-577
21. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB 2002 Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87:589-598
22. Colao A, Di Somma C, Cuocolo A, Spinelli L, Tedesco N, Pivonello R, Bonaduce D, Salvatore M, Lombardi G 2001 Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. J Clin Endocrinol Metab 86:1874-1881
23. Amato G, Mazziotti G, Di Somma C, Lalli E, De Felice G, Conte M, Rotondi M, Pietrosante M, Lombardi G, Bellastella A, Carella C, Colao A 2000 Recombinant growth hormone (GH) therapy in GH deficient adults: a long-term controlled study on daily vs. thrice weekly injections. J Clin Endocrinol Metab 85:3720-3725
24. Rubin JM, Bude RO, Carson PL, Bree RL, Adler RS 1994 Power Doppler US: a potentially useful alternative to mean frequency-based Color Doppler US. Radiology 190:853-856
25. McNeal JE 1988 Normal histology of the prostate. Am J Surg Pathol 12:619-633
26. Angelloz-Nicoud P, Binoux M 1995 Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). Endocrinology 136:5485-5492
27. Figueroa JA, Lee AV, Jackson JG, Yee D 1995 Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor (IGF) binding protein-1: evidence for an IGF-II autocrine growth loop. J Clin Endocrinol Metab 80:3476-3482
28. Plymate SR, Tennant M, Birnbaum RS, Thrasher JB, Chatta G, Ware JL 1996 The effect on the insulin-like growth factor system in human prostate epithelial cells of immortalization and transformation by simian virus-40 T antigen. J Clin Endocrinol Metab 81:3709-3716
29. Colao A, De Rosa M, Pivonello R, Balestrieri A, Cappabianca P, Di Sarno A, Rochira V, Carani C, Lombardi G 2002 Short-term suppression of growth hormone and insulin-like growth factor-I levels improves gonadal function and sperm parameters in men with acromegaly. J Clin Endocrinol Metab 87:4193-4197
30. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y 1987 The endocrinology and developmental biology of the prostate. Endocr Rev 8:338-362
31. Fiorelli G, De Bellis A, Longo A, Giannini S, Natali A, Costantini A, Vannelli GB, Serio M 1991 Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog. J Clin Endocrinol Metab 72:740-746
32. Russell PJ, Bennett S, Stricker P 1998 Growth factor involvement in progression of prostate cancer. Clin Chem 44:705-723
33. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG 1992 Prostate-specific antigen (PSA) is an insulin-growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab 75:1046-1053
34. Colao A, Di Somma C, Marzullo P, Lombardi G 2001 Growth hormone and the heart. Clin Endocrinol (Oxf) 54:137-154